SHERWIN STEPHEN A bought NBIX

June 5, 2026 · Form 4 insider transaction

SHERWIN STEPHEN A bought 10,000 shares of Neurocrine Biosciences, Inc. at $79.79 per share, a transaction worth $797.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.